Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa.

Gray GE, Huang Y, Grunenberg N, Laher F, Roux S, Andersen-Nissen E, De Rosa SC, Flach B, Randhawa AK, Jensen R, Swann EM, Bekker LG, Innes C, Lazarus E, Morris L, Mkhize NN, Ferrari G, Montefiori DC, Shen X, Sawant S, Yates N, Hural J, Isaacs A, Phogat S, DiazGranados CA, Lee C, Sinangil F, Michael NL, Robb ML, Kublin JG, Gilbert PB, McElrath MJ, Tomaras GD, Corey L.

Sci Transl Med. 2019 Sep 18;11(510). pii: eaax1880. doi: 10.1126/scitranslmed.aax1880.

PMID:
31534016
2.

Vaginal practices among women at risk for HIV acquisition in Soweto, South Africa.

Lazarus E, Otwombe K, Dietrich J, Andrasik MP, Morgan CA, Kublin JG, Gray GE, Isaacs AJ, Laher F.

South Afr J HIV Med. 2019 Jun 20;20(1):866. doi: 10.4102/sajhivmed.v20i1.866. eCollection 2019.

3.

The aspirational necessity of HIV prevention.

Corey L, Gray GE, Buchbinder SP.

J Int AIDS Soc. 2019 May;22(5):e25289. doi: 10.1002/jia2.25289. No abstract available.

4.

Recreational ART use among individuals living with HIV/AIDS in South Africa: Examining longitudinal ART initiation and viral suppression.

Magidson JF, Iyer HS, Regenauer KS, Grelotti DJ, Dietrich JJ, Courtney I, Tshabalala G, Orrell C, Gray GE, Bangsberg DR, Katz IT.

Drug Alcohol Depend. 2019 May 1;198:192-198. doi: 10.1016/j.drugalcdep.2019.02.009. Epub 2019 Mar 22.

PMID:
30953938
5.

Internalized HIV stigma, ART initiation and HIV-1 RNA suppression in South Africa: exploring avoidant coping as a longitudinal mediator.

Earnshaw VA, Bogart LM, Laurenceau JP, Chan BT, Maughan-Brown BG, Dietrich JJ, Courtney I, Tshabalala G, Orrell C, Gray GE, Bangsberg DR, Katz IT.

J Int AIDS Soc. 2018 Oct;21(10):e25198. doi: 10.1002/jia2.25198.

6.

Will the current National Strategic Plan enable South Africa to end AIDS, Tuberculosis and Sexually Transmitted Infections by 2022?

Hopkins KL, Doherty T, Gray GE.

South Afr J HIV Med. 2018 Oct 4;19(1):796. doi: 10.4102/sajhivmed.v19i1.796. eCollection 2018.

7.

Defining control of HIV epidemics.

Galvani AP, Pandey A, Fitzpatrick MC, Medlock J, Gray GE.

Lancet HIV. 2018 Nov;5(11):e667-e670. doi: 10.1016/S2352-3018(18)30178-4. Epub 2018 Oct 9.

PMID:
30314745
8.

Depression and Post Traumatic Stress amongst female sex workers in Soweto, South Africa: A cross sectional, respondent driven sample.

Coetzee J, Buckley J, Otwombe K, Milovanovic M, Gray GE, Jewkes R.

PLoS One. 2018 Jul 5;13(7):e0196759. doi: 10.1371/journal.pone.0196759. eCollection 2018.

9.

Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.

Bekker LG, Moodie Z, Grunenberg N, Laher F, Tomaras GD, Cohen KW, Allen M, Malahleha M, Mngadi K, Daniels B, Innes C, Bentley C, Frahm N, Morris DE, Morris L, Mkhize NN, Montefiori DC, Sarzotti-Kelsoe M, Grant S, Yu C, Mehra VL, Pensiero MN, Phogat S, DiazGranados CA, Barnett SW, Kanesa-Thasan N, Koutsoukos M, Michael NL, Robb ML, Kublin JG, Gilbert PB, Corey L, Gray GE, McElrath MJ; HVTN 100 Protocol Team.

Lancet HIV. 2018 Jul;5(7):e366-e378. doi: 10.1016/S2352-3018(18)30071-7. Epub 2018 Jun 18.

10.

The Challenge of Vanquishing HIV for the Next Generation-Facing the Future.

Fitzpatrick MC, Gray GE, Galvani AP.

JAMA Pediatr. 2018 Jul 1;172(7):609-610. doi: 10.1001/jamapediatrics.2018.0389. No abstract available.

PMID:
29800028
11.

Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa.

Janes H, Corey L, Ramjee G, Carpp LN, Lombard C, Cohen MS, Gilbert PB, Gray GE.

AIDS Res Hum Retroviruses. 2018 Aug;34(8):645-656. doi: 10.1089/AID.2018.0031. Epub 2018 Jun 19. Review.

12.

Mobile Phone Questionnaires for Sexual Risk Data Collection Among Young Women in Soweto, South Africa.

Dietrich JJ, Lazarus E, Andrasik M, Hornschuh S, Otwombe K, Morgan C, Isaacs AJ, Huang Y, Laher F, Kublin JG, Gray GE; HVTN 915 study team.

AIDS Behav. 2018 Jul;22(7):2312-2321. doi: 10.1007/s10461-018-2080-y.

13.

Condom migration after introduction of pre-exposure prophylaxis among HIV-uninfected adolescents in South Africa: A cohort analysis.

Maljaars LP, Gill K, Smith PJ, Gray GE, Dietrich JJ, Gomez GB, Bekker LG.

South Afr J HIV Med. 2017 Sep 21;18(1):712. doi: 10.4102/sajhivmed.v18i1.712. eCollection 2017.

14.

HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study.

Coetzee J, Hunt G, Jaffer M, Otwombe K, Scott L, Bongwe A, Ledwaba J, Molema S, Jewkes R, Gray GE.

PLoS One. 2017 Dec 15;12(12):e0188606. doi: 10.1371/journal.pone.0188606. eCollection 2017.

15.
16.

Cross-sectional study of female sex workers in Soweto, South Africa: Factors associated with HIV infection.

Coetzee J, Jewkes R, Gray GE.

PLoS One. 2017 Oct 5;12(10):e0184775. doi: 10.1371/journal.pone.0184775. eCollection 2017.

17.

Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.

Rademeyer C, Korber B, Seaman MS, Giorgi EE, Thebus R, Robles A, Sheward DJ, Wagh K, Garrity J, Carey BR, Gao H, Greene KM, Tang H, Bandawe GP, Marais JC, Diphoko TE, Hraber P, Tumba N, Moore PL, Gray GE, Kublin J, McElrath MJ, Vermeulen M, Middelkoop K, Bekker LG, Hoelscher M, Maboko L, Makhema J, Robb ML, Karim SA, Karim QA, Kim JH, Hahn BH, Gao F, Swanstrom R, Morris L, Montefiori DC, Williamson C.

PLoS Pathog. 2017 Sep 25;13(9):e1006641. doi: 10.1371/journal.ppat.1006641. eCollection 2017 Sep.

18.

A retrospective case-cohort study comparing treatment outcomes in abacavir versus stavudine containing first line antiretroviral treatment regimens in children <3yrs old, at a paediatric programme based in Soweto, South Africa.

Cassim H, Otwombe K, Lazarus E, Liberty A, Gray GE, Greeff OBW, Violari A.

PLoS One. 2017 Jul 7;12(7):e0180645. doi: 10.1371/journal.pone.0180645. eCollection 2017.

19.

Preventing acquisition of HIV is the only path to an AIDS-free generation.

Corey L, Gray GE.

Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3798-3800. doi: 10.1073/pnas.1703236114. Epub 2017 Mar 30. No abstract available.

20.

Hope for HIV control in southern Africa: The continued quest for a vaccine.

Bekker LG, Gray GE.

PLoS Med. 2017 Feb 28;14(2):e1002241. doi: 10.1371/journal.pmed.1002241. eCollection 2017 Feb.

21.

Investigating Sociodemographic Factors and HIV Risk Behaviors Associated With Social Networking Among Adolescents in Soweto, South Africa: A Cross-Sectional Survey.

Dietrich JJ, Laher F, Hornschuh S, Nkala B, Chimoyi L, Otwombe K, Kaida A, Gray GE, Miller C.

JMIR Public Health Surveill. 2016 Sep 28;2(2):e154. doi: 10.2196/publichealth.4885.

22.

Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.

Rademeyer C, Korber B, Seaman MS, Giorgi EE, Thebus R, Robles A, Sheward DJ, Wagh K, Garrity J, Carey BR, Gao H, Greene KM, Tang H, Bandawe GP, Marais JC, Diphoko TE, Hraber P, Tumba N, Moore PL, Gray GE, Kublin J, McElrath MJ, Vermeulen M, Middelkoop K, Bekker LG, Hoelscher M, Maboko L, Makhema J, Robb ML, Abdool Karim S, Abdool Karim Q, Kim JH, Hahn BH, Gao F, Swanstrom R, Morris L, Montefiori DC, Williamson C.

PLoS Pathog. 2016 Jul 19;12(7):e1005742. doi: 10.1371/journal.ppat.1005742. eCollection 2016 Jul. Erratum in: PLoS Pathog. 2017 Sep 25;13(9):e1006641.

23.

Perinatal HIV-1 transmission: Fc gamma receptor variability associates with maternal infectiousness and infant susceptibility.

Lassaunière R, Musekiwa A, Gray GE, Kuhn L, Tiemessen CT.

Retrovirology. 2016 Jun 10;13(1):40. doi: 10.1186/s12977-016-0272-y.

24.

Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap.

Gray GE, Mayer KH, Elizaga ML, Bekker LG, Allen M, Morris L, Montefiori D, De Rosa SC, Sato A, Gu N, Tomaras GD, Tucker T, Barnett SW, Mkhize NN, Shen X, Downing K, Williamson C, Pensiero M, Corey L, Williamson AL.

Clin Vaccine Immunol. 2016 Jun 6;23(6):496-506. doi: 10.1128/CVI.00717-15. Print 2016 Jun.

25.

Approaches to preventative and therapeutic HIV vaccines.

Gray GE, Laher F, Lazarus E, Ensoli B, Corey L.

Curr Opin Virol. 2016 Apr;17:104-109. doi: 10.1016/j.coviro.2016.02.010. Epub 2016 Mar 15. Review.

26.

Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02.

Leitman EM, Hurst J, Mori M, Kublin J, Ndung'u T, Walker BD, Carlson J, Gray GE, Matthews PC, Frahm N, Goulder PJ.

J Infect Dis. 2016 Aug 1;214(3):379-89. doi: 10.1093/infdis/jiw093. Epub 2016 Mar 6.

27.

Psychosocial correlates of alcohol and other substance use among low-income adolescents in peri-urban Johannesburg, South Africa: A focus on gender differences.

Magidson JF, Dietrich J, Otwombe KN, Sikkema KJ, Katz IT, Gray GE.

J Health Psychol. 2017 Sep;22(11):1415-1425. doi: 10.1177/1359105316628739. Epub 2016 Mar 1.

28.

Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?

Gray GE, Laher F, Doherty T, Abdool Karim S, Hammer S, Mascola J, Beyrer C, Corey L.

PLoS Biol. 2016 Mar 2;14(3):e1002372. doi: 10.1371/journal.pbio.1002372. eCollection 2016 Mar. Review. Erratum in: PLoS Biol. 2016 Jun;14(6):e1002487.

29.

Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples.

Magaret AS, Mujugira A, Hughes JP, Lingappa J, Bukusi EA, DeBruyn G, Delany-Moretlwe S, Fife KH, Gray GE, Kapiga S, Karita E, Mugo NR, Rees H, Ronald A, Vwalika B, Were E, Celum C, Wald A; Partners in Prevention HSV/HIV Transmission Study Team.

Clin Infect Dis. 2016 Feb 15;62(4):456-61. doi: 10.1093/cid/civ908. Epub 2015 Nov 17.

30.
31.

Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.

Moodie Z, Metch B, Bekker LG, Churchyard G, Nchabeleng M, Mlisana K, Laher F, Roux S, Mngadi K, Innes C, Mathebula M, Allen M, Bentley C, Gilbert PB, Robertson M, Kublin J, Corey L, Gray GE.

PLoS One. 2015 Sep 14;10(9):e0137666. doi: 10.1371/journal.pone.0137666. eCollection 2015.

32.

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials.

Huang Y, Follmann D, Nason M, Zhang L, Huang Y, Mehrotra DV, Moodie Z, Metch B, Janes H, Keefer MC, Churchyard G, Robb ML, Fast PE, Duerr A, McElrath MJ, Corey L, Mascola JR, Graham BS, Sobieszczyk ME, Kublin JG, Robertson M, Hammer SM, Gray GE, Buchbinder SP, Gilbert PB.

PLoS One. 2015 Sep 2;10(9):e0136626. doi: 10.1371/journal.pone.0136626. eCollection 2015.

33.

Immunogenicity and Safety of a 9-Valent HPV Vaccine.

Van Damme P, Olsson SE, Block S, Castellsague X, Gray GE, Herrera T, Huang LM, Kim DS, Pitisuttithum P, Chen J, Christiano S, Maansson R, Moeller E, Sun X, Vuocolo S, Luxembourg A.

Pediatrics. 2015 Jul;136(1):e28-39. doi: 10.1542/peds.2014-3745.

34.

A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants.

Tameris M, Hokey DA, Nduba V, Sacarlal J, Laher F, Kiringa G, Gondo K, Lazarus EM, Gray GE, Nachman S, Mahomed H, Downing K, Abel B, Scriba TJ, McClain JB, Pau MG, Hendriks J, Dheenadhayalan V, Ishmukhamedov S, Luabeya AK, Geldenhuys H, Shepherd B, Blatner G, Cardenas V, Walker R, Hanekom WA, Sadoff J, Douoguih M, Barker L, Hatherill M.

Vaccine. 2015 Jun 9;33(25):2944-54. doi: 10.1016/j.vaccine.2015.03.070. Epub 2015 Apr 28.

35.

Exposure to and experiences of violence among adolescents in lower socio-economic groups in Johannesburg, South Africa.

Otwombe KN, Dietrich J, Sikkema KJ, Coetzee J, Hopkins KL, Laher F, Gray GE.

BMC Public Health. 2015 May 1;15:450. doi: 10.1186/s12889-015-1780-8.

36.

The role of maternal, health system, and psychosocial factors in prevention of mother-to-child transmission failure in the era of programmatic scale up in western Kenya: a case control study.

Onono M, Owuor K, Turan J, Bukusi EA, Gray GE, Cohen CR.

AIDS Patient Care STDS. 2015 Apr;29(4):204-11. doi: 10.1089/apc.2014.0181. Epub 2015 Mar 4.

37.

Health-seeking behaviours by gender among adolescents in Soweto, South Africa.

Otwombe K, Dietrich J, Laher F, Hornschuh S, Nkala B, Chimoyi L, Kaida A, Gray GE, Miller CL.

Glob Health Action. 2015 Feb 2;8:25670. doi: 10.3402/gha.v8.25670. eCollection 2015.

38.

Maternal human leukocyte antigen-G (HLA-G) genetic variants associate with in utero mother-to-child transmission of HIV-1 in Black South Africans.

Hong HA, Paximadis M, Gray GE, Kuhn L, Tiemessen CT.

Infect Genet Evol. 2015 Mar;30:147-158. doi: 10.1016/j.meegid.2014.12.021. Epub 2014 Dec 23.

39.

A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component.

Bricault CA, Kovacs JM, Nkolola JP, Yusim K, Giorgi EE, Shields JL, Perry J, Lavine CL, Cheung A, Ellingson-Strouss K, Rademeyer C, Gray GE, Williamson C, Stamatatos L, Seaman MS, Korber BT, Chen B, Barouch DH.

J Virol. 2015 Mar;89(5):2507-19. doi: 10.1128/JVI.03331-14. Epub 2014 Dec 24.

40.

Understanding treatment refusal among adults presenting for HIV-testing in Soweto, South Africa: a qualitative study.

Katz IT, Dietrich J, Tshabalala G, Essien T, Rough K, Wright AA, Bangsberg DR, Gray GE, Ware NC.

AIDS Behav. 2015 Apr;19(4):704-14. doi: 10.1007/s10461-014-0920-y.

41.

Reevaluating HIV vaccine clinical trials policy for infants.

Gray GE, Corey L.

J Infect Dis. 2015 Feb 15;211(4):501-3. doi: 10.1093/infdis/jiu445. Epub 2014 Aug 27. No abstract available.

PMID:
25170103
42.

Correlates of sexual risk among sexual minority and heterosexual South African youths.

Thurston IB, Dietrich J, Bogart LM, Otwombe KN, Sikkema KJ, Nkala B, Gray GE.

Am J Public Health. 2014 Jul;104(7):1265-9. doi: 10.2105/AJPH.2013.301865. Epub 2014 May 15.

43.

Predictors of parent-adolescent communication in post-apartheid South Africa: a protective factor in adolescent sexual and reproductive health.

Coetzee J, Dietrich J, Otwombe K, Nkala B, Khunwane M, van der Watt M, Sikkema KJ, Gray GE.

J Adolesc. 2014 Apr;37(3):313-24. doi: 10.1016/j.adolescence.2014.01.006. Epub 2014 Mar 5.

44.

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study.

Gray GE, Moodie Z, Metch B, Gilbert PB, Bekker LG, Churchyard G, Nchabeleng M, Mlisana K, Laher F, Roux S, Mngadi K, Innes C, Mathebula M, Allen M, McElrath MJ, Robertson M, Kublin J, Corey L; HVTN 503/Phambili study team.

Lancet Infect Dis. 2014 May;14(5):388-96. doi: 10.1016/S1473-3099(14)70020-9. Epub 2014 Feb 20.

45.

Multiple levels of influence in predicting sexual activity and condom use among adolescents in Soweto, Johannesburg, South Africa.

Dietrich J, Sikkema K, Otwombe KN, Sanchez A, Nkala B, de Bruyn G, Van Der Watt M, Gray GE.

J HIV AIDS Soc Serv. 2013 Jul 1;12(3-4):404-423. No abstract available.

46.

A Viable and Simple Self-Sampling Method for Human Papillomavirus Detection among South African Adolescents.

Adler DH, Laher F, Lazarus E, Grzesik K, Gray GE, Allan B, Williamson AL.

J Immunol Tech Infect Dis. 2013 Sep 18;2(3). doi: 10.4172/2329-9541.1000113.

47.

KIR2DS4 allelic variants: Differential effects on in utero and intrapartum HIV-1 mother-to-child transmission.

Hong HA, Paximadis M, Gray GE, Kuhn L, Tiemessen CT.

Clin Immunol. 2013 Dec;149(3):498-508. doi: 10.1016/j.clim.2013.09.005. Epub 2013 Sep 25.

PMID:
24239756
48.

The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants.

Volk JE, Hessol NA, Gray GE, Kublin JG, Churchyard GJ, Mlisana K, Nchabeleng M, Buchbinder SP, Bekker LG.

Int J STD AIDS. 2014 Apr;25(5):332-40. doi: 10.1177/0956462413506892. Epub 2013 Oct 8.

49.

A qualitative analysis of factors influencing HPV vaccine uptake in Soweto, South Africa among adolescents and their caregivers.

Katz IT, Nkala B, Dietrich J, Wallace M, Bekker LG, Pollenz K, Bogart LM, Wright AA, Tsai AC, Bangsberg DR, Gray GE.

PLoS One. 2013 Aug 30;8(8):e72094. doi: 10.1371/journal.pone.0072094. eCollection 2013.

50.

Cautious optimism for HIV vaccine science.

Gray GE, Michael NL.

Curr Opin HIV AIDS. 2013 Sep;8(5):367-8. doi: 10.1097/01.COH.0000432529.38768.1f. No abstract available.

PMID:
23924996

Supplemental Content

Support Center